Skip to Main Content

Paper Details

RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma.
Neuro-Oncology
5
2022
-, 4768 genes, C-MYC, CBP, CPI-1612, CREB-binding protein, DNA, GBM, GBM cells, GBM22-shRBBP4 orthotopic tumors, GBM43, GBM43 patient-derived xenograft, H3K27Ac, PDX, RBBP4, TMZ, Temozolomide, enhancers, genes, glioblastoma, histone, histone H3, histone acetyltransferases, mice, orthotopic tumors, p300, patient, pro-survival genes, promoters, shNT, shNT tumors, shRBBP4, shRNAs, shp300, upregulated genes

Datasets

Release 1.2